Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)

Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to support their Phase 2 clinical trial.

Unite 2 Fight Paralysis (U2FP) is a member of Alliance for Regenerative Medicine.

This entry was posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research and tagged , , . Bookmark the permalink.